FIELD: medicine; gastroenterology.
SUBSTANCE: in patients with cholelithiasis (GSD) in combination with non-alcoholic fatty liver disease (NAFLD), the HOMA insulin resistance index, CIRS-G index are determined and, based on instrumental studies with multispiral computed tomography without contrast, the size and density of gallstones are determined. The stone density is then calculated using the Hounsfield scale (HU). Then, based on these indicators, the effectiveness of litholysis (P) is predicted using a mathematical formula. And with a P value > 0.5, the effectiveness of litholysis is predicted for choosing a conservative treatment method.
EFFECT: predicting the effectiveness of litholysis using conservative methods in the joint non-invasive treatment of combined diseases — cholelithiasis and NAFLD.
1 cl, 2 ex, 15 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EARLY DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2022 |
|
RU2798723C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN FEMALES | 2020 |
|
RU2744021C1 |
| METHOD FOR DIAGNOSING HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE WITH TYPE 2 DIABETES MELLITUS | 2019 |
|
RU2732526C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANYING METABOLIC SYNDROME | 2018 |
|
RU2686042C1 |
| METHOD OF NON-INVASIVE DIAGNOSTICS OF FIBROSIS IN CASE OF DIFFUSE LIVERE DISEASES | 2010 |
|
RU2422091C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME WITH VITAMIN D DEFICIENCY | 2018 |
|
RU2694842C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES MELLITUS | 2018 |
|
RU2706026C1 |
| METHOD OF TREATING PATIENTS SUFFERING FROM FIRST STAGE CHOLELITHIASIS | 2012 |
|
RU2519198C2 |
| METHOD OF DIAGNOSTICS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN METABOLIC SYNDROME | 2022 |
|
RU2803945C1 |
| METHOD OF NON-INVASIVE DIAGNOSTICS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN MEN | 2023 |
|
RU2803074C1 |
